140 related articles for article (PubMed ID: 2538970)
1. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
Petru E; Berger MR; Zeller WJ; Kaufmann M
Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man.
Petru E; Berger MR; Zeller WJ; Kaufmann M
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapeutic characterization of new nitrosourea compounds].
Zeller WJ; Berger MR; Eisenbrand G; Petru E
Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
[TBL] [Abstract][Full Text] [Related]
5. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
Yanapirut P; Berger MR; Reinhardt M; Schmähl D
Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vivo and in vitro activity of estrogen-linked nitrosoureas in methylnitrosourea-induced rat mammary carcinoma.
Petru E; Berger MR; Kaufmann M
J Cancer Res Clin Oncol; 1988; 114(3):317-20. PubMed ID: 3384846
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cytosolic sexual steroid receptors in autochthonous methylnitrosourea-induced rat mammary carcinoma following application of 2-chloroethylnitrosocarbamoyl-L-alanine linked to oestradiol or dihydrotestosterone.
Corr R; Berger MR; Betsch B; Floride JA; Brix HP; Schmähl D
Br J Cancer; 1990 Jul; 62(1):42-7. PubMed ID: 2390481
[TBL] [Abstract][Full Text] [Related]
8. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF
Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344
[TBL] [Abstract][Full Text] [Related]
9. An oestradiol-linked nitrosourea and site-directed chemotherapy in mammary carcinoma.
Betsch B; Berger MR; Spiegelhalder B; Schmähl D; Eisenbrand G
Eur J Cancer; 1990; 26(8):895-8. PubMed ID: 2145934
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions.
Berger MR; Floride J; Schmähl D; Schreiber J; Eisenbrand G
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1179-91. PubMed ID: 3816911
[TBL] [Abstract][Full Text] [Related]
11. Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay.
Manni A; Wright C; Pontari M; Feil P; Joehl R
J Natl Cancer Inst; 1985 Apr; 74(4):767-70. PubMed ID: 2985856
[TBL] [Abstract][Full Text] [Related]
12. Influence of estradiol and tamoxifen on the growth of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar.
Arafah BM; Gordon NH; Wilhite BL; Pearson OH
Cancer Res; 1984 Jul; 44(7):2869-72. PubMed ID: 6722815
[TBL] [Abstract][Full Text] [Related]
13. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
14. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites.
Betsch B; Berger MR; Spiegelhalder B
Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936
[TBL] [Abstract][Full Text] [Related]
15. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
von Angerer E; Birnböck H; Knebel N
Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
[TBL] [Abstract][Full Text] [Related]
16. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
[TBL] [Abstract][Full Text] [Related]
17. [In vitro hormone tests in human breast cancers and their relevance for therapy of metastasizing breast cancer].
Schönfelder M
Zentralbl Chir; 1987; 112(18):1150-4. PubMed ID: 3687263
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
[TBL] [Abstract][Full Text] [Related]
19. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
[TBL] [Abstract][Full Text] [Related]
20. Autocrine stimulation by estradiol-regulated growth factors of rat hormone-responsive mammary cancer: interaction with the polyamine pathway.
Manni A; Wright C; Feil P; Baranao L; Demers L; Garcia M; Rochefort H
Cancer Res; 1986 Apr; 46(4 Pt 1):1594-8. PubMed ID: 3081252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
